- ISIN DE0005227235
- Country Deutschland
Latest Reports
News Functions
Additional Functions
14 November 2024
Biotest AG
Q3 statement / Q3 financial report 2024
Biotest AG
Quartalsergebnisse Q1-Q3 – November 2024
Biotest AG
Quarterly Results Q1-Q3 – November 2024
Biotest AG
Q3 Mitteilung / Q3 Finanzbericht 2024
6 August 2024
Biotest AG
Half-yearly financial report 2024
Biotest AG
Halbjahresfinanzbericht 2024
Biotest AG
Half Year Results 2024 – August 2024
Biotest AG
Präsentation zum Halbjahr 2024 – August 2024
7 May 2024
Biotest AG
Q1 statement / Q1 financial report 2024
29 April 2024
Biotest AG
Annual financial report 2023
Biotest AG
Jahresfinanzbericht 2023
25 April 2024
Biotest AG
Analystenkonferenz zum Finanzjahr 2023 – März 2024
28 March 2024
Biotest AG
Full Year Results 2023 – March 2024
Biotest AG
Geschäftsbericht 2023
6 November 2023
Biotest AG
Q3 statement / Q3 financial report 2023
2 November 2023
Biotest AG
Quartalsergebnisse Q1-Q3 – November 2023
Biotest AG
Quarterly Results Q1-Q3 – November 2023
10 August 2023
Biotest AG
Half-yearly financial report 2023
9 May 2023
Biotest AG
Q1 statement / Q1 financial report 2023
23 March 2023
Biotest AG
Vergütungsbericht 2022
Biotest AG
Remunerations Report 2022
Biotest AG
Analystenkonferenz zum Finanzjahr 2022 – März 2023
Biotest AG
Geschäftsbericht 2022 (ESEF)
Biotest AG
Geschäftsbericht 2022
Biotest AG
Full Year Results 2022– March 2023
Biotest AG
Annual financial report 2022
Latest News
News Functions
Additional Functions
15 November 2024
Biotest AG
Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest’s plasma center in Darmstadt and call for plasma donations
14 November 2024
Biotest AG
Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million
Biotest AG
Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged
29 October 2024
Biotest AG
Biotest and SteinCares partner to improve access to plasma-derived products in Latin America
2 October 2024
Biotest AG
Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July
12 September 2024
Biotest AG
Change in the Chief Financial Officer at Biotest AG